BANDUNG — Human trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned pharmaceutical company Bio Farma and China’s Sinovac Biotech Ltd, a senior researcher said.
The launch of the vaccine trial comes as Indonesia has struggled to contain the spread of the novel coronavirus, with a consistently escalating number of cases.
The phase 3 clinical trial is set to begin on Aug. 11 and will involve 1,620 volunteers aged between 18 and 59, Professor Kusnandi Rusmil, head researcher at Bandung’s Padjadjaran University, told reporters.
Half of the participants will receive the vaccine over a six-month period, while the rest will receive a placebo, he said, noting 800 volunteers had been signed up so far.
“We want to have our vaccines so we can use it for our people,” Rusmil told reporters.
As of Wednesday, Indonesia had recorded 116,871 coronavirus infections and 5,432 deaths – the highest in East Asia.